by Alex Kadhim
Researchers at the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation have found that haploidentical transplantation with posttransplant cyclophosphamide...
by Alex Kadhim
Researchers at MD Anderson Cancer Center have determined that donor age has a stronger, nonlinear impact on overall survival compared to donor type in allogeneic HCT using posttransplant...
by Alex Kadhim
Researchers from the European Society for Blood and Marrow Transplantation (EBMT) conducted a large registry-based analysis comparing haploidentical donors (HID) and older matched sibling donors...
by Alex Kadhim
Researchers at the Children’s Hospital of Philadelphia and collaborators evaluated outcomes of unrelated donor peripheral blood stem cell transplantation (URD-PSCT) with partial T cell...
by Alex Kadhim
Researchers at Memorial Sloan Kettering Cancer Center have found the addition of tocilizumab, an interleukin-6 receptor blocker, to standard GVHD prophylaxis modestly reduces inflammation-related...
by Alex Kadhim
Researchers from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) reported that posttransplant cyclophosphamide (PTCy)-based GVHD prophylaxis significantly improves outcomes for...